Skip to main content
Hit enter to search or ESC to close
Close Search
Action Santé Mondiale
  • Home
  • Identity
  • Causes
    • Fight against pandemics
    • Women and Child’s Health
    • Funding and quality of aid
    • Research and Development
    • All our causes
  • Opinions
  • Resources
  • Contact
  • French
  Women and children's health

Guaranteeing access to
immunisation for all

What’s at stake?

Between 1980 and 2010, immunisation helped cut child mortality rates by half and decreased by 90% the global incidence of many infectious diseases such as tetanus, diphtheria, measles, polio or whooping cough. However, global vaccination rates are stagnating and 19.4 million children still do not have access to basic vaccines.

France’s investment into global immunisation is done via Gavi, the Vaccines Alliance, a public-private partnership created in 2000, which works to improve access to immunisation for children living in the world’s poorest countries. This initiative allows to buy vaccines at affordable prices by ensuring demand and competition on the vaccines market. Gavi’s core objective is to protect children’s lives and public health by improving the use of vaccines in developing countries.

Global vaccination coverage gaps have consequences. Diseases which were previously under control can emerge again, as is the case of measles in the Democratic Republic of Congo. In developing countries, millions of people continue to suffer and die, which affect already underfinanced health systems.

Major progress in recent years are also threatened by the COVID19 pandemic. Vaccination services are on hold or being postponed in order to prevent gatherings that could lead to transmission of the virus in communities. Many have raised the alarm on the risk of measles and polio resurgence, which could cause more deaths than COVID19. 80 millions children under one year old risk contracting preventable diseases because of basic vaccine systems’ disruption.

Our asks:

We believe equal access to vaccines should be guaranteed to all children and adults. We’re asking:

  • France and the EU to maintain ambitious financing pledges towards Gavi, the Vaccine Alliance : the partnership’s efficiency is no longer to be demonstrated and the strategy it pursues corresponds to the priorities of France and the EU in terms of Health Systems Strengthening (HSS), the fight against inequalities in terms of health and gender, and domestic resource mobilisation.
  • That all populations, including in low income countries have access to immunization, strong health systems equipped with a qualified health workforce in all communities, sufficient and sustainable finances and stronger procurement systems.
  • That France and the EU actively participate in the realisation of Universal Health Coverage (UHC) in order to eliminate financial barriers to child immunization.
  • That the crucial role of civil society and communities be recognised in terms of prevention, especially among most marginalised groups, as well as their efforts to increase acceptability and vaccine use in those communities ; that national budgets and development aid support those community actors.
  • That the international community commits to take all necessary measures to ensure that, when available, the future COVID19 vaccines be accessible to all, especially in most fragile countries and among most vulnerable groups.

At the onset of the pandemic, many European Heads of States underlined the necessity to make future medical technologies against COVID19 « global public goods ». However, no concrete measure has been put in place to date to guarantee universal access to COVID19 products, notably vaccines for which half of the doses have already been bought off by rich countries, who only represent 13% of the world’s population. Maintaining intellectual property barriers on those products (TRIPS agreement) impede on increasing production, reduces diversity in terms of manufacturers and refrain competition, which would translate into lower prices. Neither France nor the EU have supported the proposal to temporarily waive those restrictions, backed by almost 100 countries.

Share Tweet Share

Global Health Advocates is a French NGO which mission is to carry out political advocacy in France and with the EU institutions to ensure policies and resources are effectively addressing health inequalities.

Adresses

Paris Office

Global Health Advocates France
176 rue du Temple
75 003 Paris

Advocacy team
Tel : +33 9 81 85 33 16
Finance & administration
info@ghadvocates.org

Brussels Office

Mundo J
Rue de l’Industrie 10
1000, Brussels

Advocacy Team
Tel: +32 (0) 2 669 42 56

Réseaux sociaux

GHA France Follow

Action Santé Mondiale/Global Health Advocates ONG de plaidoyer qui lutte pour un accès à la #santé pour tou·te·s auprès des institutions FR & UE @GHABrussels

GHAFrance
ghafrance GHA France @ghafrance ·
8 Mar

En cette journée des droits des femmes #IWD2023 ♀, @GHAFrance participe à la présentation des priorités de la diplomatie #féministe de la France 🇫🇷 par @MinColonna. On attend avec impatience le lancement de la nouvelle stratégie internationale de la France en matière de #DSSR ⚕️

Reply on Twitter 1633498972403777538 Retweet on Twitter 1633498972403777538 4 Like on Twitter 1633498972403777538 8 Twitter 1633498972403777538

GHA EU Follow

Global Health Advocates / Action Santé Mondiale Advocacy NGO that fights for #HealthforAll at the #EU level & in France @GHAFrance

GHABrussels
ghabrussels GHA EU @ghabrussels ·
9 Mar

🤝Alongside 19 partner organisations, @GHABrussels call on the @EU_Commission to publish the proposed revision of the EU 🇪🇺 #pharma legislation in March. We cannot have more delays!
See our joint letter 🔗https://www.ghadvocates.eu/joint-letter-requesting-publication-proposed-revision-eu-pharmaceutical-legislation/

Reply on Twitter 1633877856446210049 Retweet on Twitter 1633877856446210049 Like on Twitter 1633877856446210049 2 Twitter 1633877856446210049

Contact us

    © Action Santé Mondiale 2020 - Tous droits réservés - Mentions légales

    Close Menu
    • Home
    • Identity
    • Causes
      • Fight against pandemics
      • Women and Child’s Health
      • Funding and quality of aid
      • Research and Development
      • All our causes
    • Opinions
    • Resources
    • Contact
    • French